Interstitial Lung Disease (ILD) and Idiopathic Pulmonary Fibrosis (IPF) Make an Appointment Ask a Question Search Conditions Hear about the latest developments in research and treatment of interstitial lung diseases (ILD). Particular emphasis will be on idiopathic pulmonary fibrosis (IPF), one of more than 130 types of ILD, which is characterized by scarring and/or inflammation of the interstitium - the area surrounding the air sacs at the end of each airway in the lungs. To sign up for future Dialogue with a Doc discussions, please visit njhealth.org/DocSeries Related Videos COVID-19 and Respiratory Illness: A Research & Treatment Update Asthma Research & Treatment and COVID-19 Advancements in Childhood and Adult Allergy Research and Treatment Chronic Obstructive Pulmonary Disease (COPD) and the Impact of COVID-19 Cardiology and the Impact of COVID-19: The Link Between the Heart and the Lung Nontuberculous Mycobacteria (NTM), Bronchiectasis and COVID-19: Research and Treatment Update Autoimmune Diseases, the Impact of COVID-19 and Vaccine Development Gastroenterology: The Gut, the Lung and Beyond Heart Health: Prevention, Lifestyle and Wellness Exercise Intolerance: Breathing Trouble When Exercising COVID-19 Update: What We Know and the Answers We Seek The Intersection of Autoimmune Diseases and the Lung Making Strides in the Treatment of Cystic Fibrosis Big Impact Ideas: Our Next Life-Changing Discoveries Big Impact Idea: Prevention of Pediatric Allergies and Asthma Want to use this on your website? Fill out the content usage request form and then copy this code: